Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Accelerated Phase Who Are Refractory to Imatinib Mesylate (Gleevec)

University of Texas MD Anderson Cancer Center, Houston

City of Hope Medical Center, Duarte

Scripps Clinic, Escondido

USC/Norris Cancer Center, Los Angeles

Metro-Minnesota CCOP, Saint Louis Park

New York Medical College, Valhalla

Liberty Hematology/Oncology, Columbia

Princess Margaret Hospital, Toronto